Results 161 to 170 of about 265,775 (287)
Development and Characterization of Novel Selective, Non-Basic Dopamine D2 Receptor Antagonists for the Treatment of Schizophrenia [PDF]
Piotr Stępnicki +12 more
openalex +1 more source
This paper reports a fundamental study of the mutual benefits of the components in an MXene/PNIPAAm hydrogel composite with regard to enhanced degradation stability and tailorable electronic properties. The presented work focuses on the investigation of the fundamental material properties and ways for their modification.
Sitao Wang +3 more
wiley +1 more source
In Parkinson's disease, SHMT1 downregulation disrupts its interaction with PEMT in astrocytes, reducing SAM levels. This leads to H3K4me1 hypomethylation and decreased Slc1a2/Glul expression, ultimately exacerbating neuroexcitotoxicity and dopaminergic neuron loss.
Yue‐Han Chen +17 more
wiley +1 more source
Abnormally high expression of D1-like dopamine receptors on lupus CD4+ T cells promotes Tfh cell differentiation. [PDF]
Wu F +6 more
europepmc +1 more source
Burst-Timing-Dependent Plasticity of NMDA Receptor-Mediated Transmission in Midbrain Dopamine Neurons [PDF]
Mark T. Harnett +3 more
openalex +1 more source
A fully edible soft electrode is engineered from Ca2⁺‐crosslinked alginate integrated with polydopamine, silver nanoparticles, and food‐grade glucose oxidase. The hybrid hydrogel combines ionic and electronic conduction, enabling efficient glucose‐to‐H2O2 conversion and catalytic reduction in simulated intestinal fluid.
Verdiana Marchianò +10 more
wiley +1 more source
Blocking D2/D3 dopamine receptors in male participants increases volatility of beliefs when learning to trust others. [PDF]
Mikus N +7 more
europepmc +1 more source
Facilitation of fear extinction by novelty depends on dopamine acting on D1-subtype dopamine receptors in hippocampus [PDF]
Jefferson Menezes +7 more
openalex +1 more source
GPCRs in CAR‐T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy
Chimeric antigen receptor T cell therapy faces dual challenges of target scarcity and an immunosuppressive microenvironment in solid tumors. This review highlights how G protein‐coupled receptors can serve as both novel targets to expand the therapeutic scope and functional modules to enhance CAR‐T cell efficacy.
Zhuoqun Liu +11 more
wiley +1 more source

